Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: CISPLATIN, . Treffer: 125

2023

Terbuch, A; Walser, G; Stotz, M; Gerger, A; Posch, F; Bauernhofer, T Primary Thromboprophylaxis and the Risk of Venous Thromboembolic Events in Patients With Testicular Germ Cell Tumors Treated With Cisplatinum-Based Chemotherapy.
Clin Genitourin Cancer. 2023; 21(1):24-31 Doi: 10.1016/j.clgc.2022.10.005
Web of Science PubMed FullText FullText_MUG

 

2022

Dieckmann, KP; Pokrivcak, T; Geczi, L; Niehaus, D; Dralle-Filiz, I; Matthies, C; Dienes, T; Zschabitz, S; Paffenholz, P; Gschliesser, T; Pichler, R; Mego, M; Bader, P; Zengerling, F; Heinzelbecker, J; Krausewitz, P; Krege, S; Aurilio, G; Aksoy, C; Hentrich, M; Seidel, C; Torzsok, P; Nestler, T; Majewski, M; Hiester, A; Buchler, T; Vallet, S; Studentova, H; Schonburg, S; Niedersuss-Beke, D; Ring, J; Trenti, E; Heidenreich, A; Wulfing, C; Isbarn, H; Pichlmeier, U; Pichler, M Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study
THER ADV MED ONCOL. 2022; 14: 17588359221086813 Doi: 10.1177/17588359221086813 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Hecht, M; Eckstein, M; Rutzner, S; von, der, Grün, J; Illmer, T; Klautke, G; Laban, S; Hautmann, MG; Brunner, TB; Tamaskovics, B; Hinke, A; Zhou, JG; Frey, B; Donaubauer, AJ; Becker, I; Semrau, S; Hartmann, A; Balermpas, P; Budach, W; Gaipl, US; Iro, H; Gostian, AO; Fietkau, R Induction chemoimmunotherapy followed by CD8+ immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancer.
J Immunother Cancer. 2022; 10(1): Doi: 10.1136/jitc-2021-003747 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Klingseisen, V; Slanovc, J; Regouc, M; Hrzenjak, A Bisdemethoxycurcumin sensitizes the response of cisplatin resistant non-small cell lung carcinoma cell lines by activating apoptosis and autophagy
J NUTR BIOCHEM. 2022; 106: 109003 Doi: 10.1016/j.jnutbio.2022.109003
Web of Science PubMed FullText FullText_MUG

 

Mathilakathu, A; Wessolly, M; Mairinger, E; Uebner, H; Kreidt, D; Brcic, L; Steinborn, J; Greimelmaier, K; Wohlschlaeger, J; Schmid, KW; Mairinger, FD; Borchert, S Cancer-Associated Fibroblasts Regulate Kinase Activity in Mesothelioma Cell Lines via Paracrine Signaling and Thereby Dictate Cell Faith and Behavior.
Int J Mol Sci. 2022; 23(6): Doi: 10.3390/ijms23063278 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Terbuch, A; Posch, F; Bauernhofer, T; Jost, PJ; Partl, R; Stranzl-Lawatsch, H; Baciarello, G; Fizazi, K; Giannatempo, P; Verzoni, E; Sweeney, C; Ravi, P; Tran, B; Basso, U; White, J; Vincenzi, B; Oing, C; Cutuli, HJ; Dieckmann, KP; Gamulin, M; Chovanec, M; Fankhauser, CD; Heidenreich, A; Mohamad, O; Thibault, C; Fischer, S; Gillessen, S, , International, Germ, Cell, Cancer, Collaborative, Group Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2022; 113(4):825-832 Doi: 10.1016/j.ijrobp.2022.03.021
Web of Science PubMed FullText FullText_MUG

 

2021

Beyer, J; Collette, L; Sauvé, N; Daugaard, G; Feldman, DR; Tandstad, T; Tryakin, A; Stahl, O; Gonzalez-Billalabeitia, E; De, Giorgi, U; Culine, S; de, Wit, R; Hansen, AR; Bebek, M; Terbuch, A; Albany, C; Hentrich, M; Gietema, JA; Negaard, H; Huddart, RA; Lorch, A; Cafferty, FH; Heng, DYC; Sweeney, CJ; Winquist, E; Chovanec, M; Fankhauser, C; Stark, D; Grimison, P; Necchi, A; Tran, B; Heidenreich, A; Shamash, J; Sternberg, CN; Vaughn, DJ; Duran, I; Bokemeyer, C; Patrikidou, A; Cathomas, R; Assele, S; Gillessen, S, , International, Germ, Cell, Cancer, Classification, Update, Consortium Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium.
J Clin Oncol. 2021; 39(14):1553-1562 Doi: 10.1200/JCO.20.03292 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gillessen, S; Sauvé, N; Collette, L; Daugaard, G; de, Wit, R; Albany, C; Tryakin, A; Fizazi, K; Stahl, O; Gietema, JA; De, Giorgi, U; Cafferty, FH; Hansen, AR; Tandstad, T; Huddart, RA; Necchi, A; Sweeney, CJ; Garcia-Del-Muro, X; Heng, DYC; Lorch, A; Chovanec, M; Winquist, E; Grimison, P; Feldman, DR; Terbuch, A; Hentrich, M; Bokemeyer, C; Negaard, H; Fankhauser, C; Shamash, J; Vaughn, DJ; Sternberg, CN; Heidenreich, A; Beyer, J, , International, Germ, Cell, Cancer, Classification, Update, Consortium Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium.
J Clin Oncol. 2021; 39(14):1563-1574 Doi: 10.1200/JCO.20.03296 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Keil, F; Hartl, M; Altorjai, G; Berghold, A; Riedl, R; Pecherstorfer, M; Mayrbaurl, B; De Vries, A; Schuster, J; Hackl, J; Fureder, T; Melchardt, T; Burian, M; Greil, R Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trial
EUR J CANCER. 2021; 151: 201-210. Doi: 10.1016/j.ejca.2021.03.051
Web of Science PubMed FullText FullText_MUG

 

Posch, F; Prinz, F; Balihodzic, A; Mayr, C; Kiesslich, T; Klec, C; Jonas, K; Barth, DA; Riedl, JM; Gerger, A; Pichler, M MiR-200c-3p Modulates Cisplatin Resistance in Biliary Tract Cancer by ZEB1-Independent Mechanisms.
Cancers (Basel). 2021; 13(16): Doi: 10.3390/cancers13163996 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rouprêt, M; Babjuk, M; Burger, M; Capoun, O; Cohen, D; Compérat, EM; Cowan, NC; Dominguez-Escrig, JL; Gontero, P; Hugh Mostafid, A; Palou, J; Peyronnet, B; Seisen, T; Soukup, V; Sylvester, RJ; Rhijn, BWGV; Zigeuner, R; Shariat, SF European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update.
Eur Urol. 2021; 79(1):62-79 Doi: 10.1016/j.eururo.2020.05.042 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Semrau, S; Gostian, AO; Traxdorf, M; Eckstein, M; Rutzner, S; von, der, Grün, J; Illmer, T; Hautmann, M; Klautke, G; Laban, S; Brunner, T; Tamaskovics, B; Frey, B; Zhou, JG; Geppert, CI; Hartmann, A; Balermpas, P; Budach, W; Gaipl, U; Iro, H; Fietkau, R; Hecht, M Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck Cancer.
Cancers (Basel). 2021; 13(8): Doi: 10.3390/cancers13081959 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Thorne, LS; Rochford, G; Williams, TD; Southam, AD; Rodriguez-Blanco, G; Dunn, WB; Hodges, NJ Cytoglobin protects cancer cells from apoptosis by regulation of mitochondrial cardiolipin.
Sci Rep. 2021; 11(1): 985 Doi: 10.1038/s41598-020-79830-w [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2020

Fischer, S; Tandstad, T; Cohn-Cedermark, G; Thibault, C; Vincenzi, B; Klingbiel, D; Albany, C; Necchi, A; Terbuch, A; Lorch, A; Aparicio, J; Heidenreich, A; Hentrich, M; Wheater, M; Langberg, CW; Ståhl, O; Fankhauser, CD; Hamid, AA; Koutsoukos, K; Shamash, J; White, J; Bokemeyer, C; Beyer, J; Gillessen, S, , Global, Germ-Cell, Cancer, Group Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma.
J Clin Oncol. 2020; 38(12):1322-1331 Doi: 10.1200/JCO.19.01876 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Hecht, M; Gostian, AO; Eckstein, M; Rutzner, S; von, der, Grün, J; Illmer, T; Hautmann, MG; Klautke, G; Laban, S; Brunner, T; Hinke, A; Becker, I; Frey, B; Semrau, S; Geppert, CI; Hartmann, A; Balermpas, P; Budach, W; Gaipl, US; Iro, H; Fietkau, R Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8.
J Immunother Cancer. 2020; 8(2): Doi: 10.1136/jitc-2020-001378 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Klöckl, MC; Kasparek, AK; Riedl, JM; Moik, F; Mollnar, S; Stotz, M; Szkandera, J; Terbuch, A; Gerger, A; Niedrist, T; Pichler, M; Bauernhofer, T; Schilcher, G; Zitta, S; Rosenkranz, AR; Friedl, C; Stöger, H; Posch, F Estimation versus measurement of the glomerular filtration rate for kidney function assessment in patients with cancer undergoing cisplatin-based chemotherapy.
Sci Rep. 2020; 10(1):11219 Doi: 10.1038/s41598-020-68010-5 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Seidl, C; Panzitt, K; Bertsch, A; Brcic, L; Schein, S; Mack, M; Leithner, K; Prinz, F; Olschewski, H; Kornmueller, K; Hrzenjak, A MicroRNA-182-5p regulates hedgehog signaling pathway and chemosensitivity of cisplatin-resistant lung adenocarcinoma cells via targeting GLI2.
Cancer Lett. 2020; 469: 266-276. Doi: 10.1016/j.canlet.2019.10.044
Web of Science PubMed FullText FullText_MUG

 

2018

Dietz, A; Wichmann, G; Kuhnt, T; Pfreundner, L; Hagen, R; Scheich, M; Kölbl, O; Hautmann, MG; Strutz, J; Schreiber, F; Bockmühl, U; Schilling, V; Feyer, P; de Wit, M; Maschmeyer, G; Jungehülsing, M; Schroeder, U; Wollenberg, B; Sittel, C; Münter, M; Lenarz, T; Klussmann, JP; Guntinas-Lichius, O; Rudack, C; Eich, HT; Foerg, T; Preyer, S; Westhofen, M; Welkoborsky, HJ; Esser, D; Thurnher, D; Remmert, S; Sudhoff, H; Görner, M; Bünzel, J; Budach, V; Held, S; Knödler, M; Lordick, F; Wiegand, S; Vogel, K; Boehm, A; Flentje, M; Keilholz, U Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II.
Ann Oncol. 2018; 29(10): 2105-2114. Doi: 10.1093/annonc/mdy332 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Frille, A; Leithner, K; Olschewski, A; Olschewski, H; Wohlkönig, C; Hrzenjak, A No erythropoietin-induced growth is observed in non-small cell lung cancer cells.
Int J Oncol. 2018; 52(2): 518-526. Doi: 10.3892/ijo.2017.4225 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rinnerthaler, G; Gampenrieder, SP; Petzer, A; Burgstaller, S; Fuchs, D; Rossmann, D; Balic, M; Egle, D; Rumpold, H; Singer, CF; Bartsch, R; Petru, E; Melchardt, T; Ulmer, H; Mlineritsch, B; Greil, R Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial).
BMC CANCER. 2018; 18(1): 1074-1074. Doi: 10.1186/s12885-018-4979-0 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Terbuch, A; Posch, F; Partl, R; Zurl, B; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Kapp, KS; Stöger, H; Gerger, A; Stotz, M Risk stratification for febrile neutropenia in patients with testicular germ cell tumors.
Cancer Med. 2018; 7(2):508-514 Doi: 10.1002/cam4.1317 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2017

Barac, A; Mitulovic, G; Hallström, S; Zehetmayer, S; Grasl, MC; Erovic, BM Impact of combined treatment with nimesulide and cisplatin on oral carcinoma cells.
Onco Targets Ther. 2017; 10(6):3607-3616 Doi: 10.2147/OTT.S131106 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Dulz, S; Asselborn, NH; Dieckmann, KP; Matthies, C; Wagner, W; Weidmann, J; Seidel, C; Oing, C; Berger, LA; Alsdorf, W; Mankichian, B; Meyer, C; Vetterlein, MW; Gild, P; Ludwig, TA; Soave, A; Schriefer, P; Becker, A; Ahyai, SA; Oechsle, K; Bokemeyer, C; Wagenfeld, L; Fisch, M; Hartmann, M; Chun, FK; Kluth, LA Retinal toxicity after cisplatin-based chemotherapy in patients with germ cell cancer.
J Cancer Res Clin Oncol. 2017; 143(7):1319-1325 Doi: 10.1007/s00432-017-2384-8
Web of Science PubMed FullText FullText_MUG

 

Enzenhofer, E; Kadletz, L; Stanisz, I; Kotowski, U; Seemann, R; Schmid, R; Thurnher, D; Heiduschka, G Effect of the histone deacetylase inhibitor resminostat on head and neck squamous cell carcinoma cell lines.
Head Neck. 2017; 39(5):900-907 Doi: 10.1002/hed.24699
Web of Science PubMed FullText FullText_MUG

 

Fadejeva, I; Olschewski, H; Hrzenjak, A MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas.
Oncotarget. 2017; 8(70):115754-115773 Doi: 10.18632/oncotarget.22975 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Ferrari, S; Bielack, SS; Smeland, S; Longhi, A; Egerer, G; Sundby Hall, K; Donati, D; Kevric, M; Brosjö, O; Comandone, A; Werner, M; Monge, O; Palmerini, E; Berdel, WE; Bjerkehagen, B; Paioli, A; Lorenzen, S; Eriksson, M; Gambarotti, M; Tunn, PU; Jebsen, NL; Cesari, M; von Kalle, T; Ferraresi, V; Schwarz, R; Bertulli, R; Kasparek, AK; Grignani, G; Krasniqi, F; Sorg, B; Hecker-Nolting, S; Picci, P; Reichardt, P EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma.
Tumori. 2017; 104(1):30-36 Doi: 10.5301/tj.5000696
Web of Science PubMed FullText FullText_MUG

 

Katanić, J; Matić, S; Pferschy-Wenzig, EM; Kretschmer, N; Boroja, T; Mihailović, V; Stanković, V; Stanković, N; Mladenović, M; Stanić, S; Mihailović, M; Bauer, R Filipendula ulmaria extracts attenuate cisplatin-induced liver and kidney oxidative stress in rats: In vivo investigation and LC-MS analysis.
Food Chem Toxicol. 2017; 99(2):86-102 Doi: 10.1016/j.fct.2016.11.018
Web of Science PubMed FullText FullText_MUG

 

Kotowski, U; Heiduschka, G; Kadletz, L; Fahim, T; Seemann, R; Schmid, R; Schneider, S; Mitterbauer, A; Thurnher, D Effect of thymoquinone on head and neck squamous cell carcinoma cells in vitro: Synergism with radiation.
Oncol Lett. 2017; 14(1):1147-1151 Doi: 10.3892/ol.2017.6189 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kotowski, U; Kadletz, L; Schneider, S; Foki, E; Schmid, R; Seemann, R; Thurnher, D; Heiduschka, G 6-shogaol induces apoptosis and enhances radiosensitivity in head and neck squamous cell carcinoma cell lines.
Phytother Res. 2017; Doi: 10.1002/ptr.5982
Web of Science PubMed FullText FullText_MUG

 

Lill, C; Bachtiary, B; Selzer, E; Mittlboeck, M; Thurnher, D A 5‑year update of patients with HPV positive versus negative oropharyngeal cancer after radiochemotherapy in Austria.
Wien Klin Wochenschr. 2017; 129(11-12):398-403 Doi: 10.1007/s00508-017-1171-5 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Longhi, A; Bielack, SS; Grimer, R; Whelan, J; Windhager, R; Leithner, A; Gronchi, A; Biau, D; Jutte, P; Krieg, AH; Klenke, FM; Grignani, G; Donati, DM; Capanna, R; Casanova, J; Gerrand, C; Bisogno, G; Hecker-Nolting, S; De Lisa, M; D'Ambrosio, L; Willegger, M; Scoccianti, G; Ferrari, S Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients.
Eur J Cancer. 2017; 74(1):9-16 Doi: 10.1016/j.ejca.2016.12.016 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Mairinger, FD; Vollbrecht, C; Flom, E; Christoph, DC; Schmid, KW; Kollmeier, J; Popper, HH; Mairinger, T; Walter, RFH Folic acid phenotype (FAP) is a superior biomarker predicting response to pemetrexed-based chemotherapy in malignant pleural mesothelioma.
Oncotarget. 2017; 8(23):37502-37510 Doi: 10.18632/oncotarget.16398 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Račkauskas, R; Zhou, D; Ūselis, S; Strupas, K; Herr, I; Schemmer, P Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti-apoptotic proteins.
Oncol Rep. 2017; 37(6):3660-3666 Doi: 10.3892/or.2017.5622 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Tiran, V; Lindenmann, J; Brcic, L; Heitzer, E; Stanzer, S; Tabrizi-Wizsy, NG; Stacher, E; Stoeger, H; Popper, HH; Balic, M; Dandachi, N Primary patient-derived lung adenocarcinoma cell culture challenges the association of cancer stem cells with epithelial-to-mesenchymal transition.
Sci Rep. 2017; 7(1):10040-10040 Doi: 10.1038/s41598-017-09929-0 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Ugurel, S; Loquai, C; Terheyden, P; Schadendorf, D; Richtig, E; Utikal, J; Gutzmer, R; Rass, K; Sunderkotter, C; Stein, A; Fluck, M; Kaatz, M; Trefzer, U; Kahler, K; Stadler, R; Berking, C; Holler, C; Kerschke, L; Edler, L; Kopp-Schneider, A; Becker, JC Chemosensitivity-directed therapy compared to dacarbazine in chemo-naive advanced metastatic melanoma: a multicenter randomized phase-3 DeCOG trial
ONCOTARGET. 2017; 8(44): 76029-76043. Doi: 10.18632/oncotarget.18635 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Brambilla, E; Le Teuff, G; Marguet, S; Lantuejoul, S; Dunant, A; Graziano, S; Pirker, R; Douillard, JY; Le Chevalier, T; Filipits, M; Rosell, R; Kratzke, R; Popper, H; Soria, JC; Shepherd, FA; Seymour, L; Tsao, MS Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer.
J CLIN ONCOL. 2016; 34(11): 1223-1230. Doi: 10.1200/JCO.2015.63.0970 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Czink, E; Heining, C; Weber, TF; Lasitschka, F; Schemmer, P; Schirmacher, P; Weiss, KH; Glimm, H; Brors, B; Weichert, W; Jäger, D; Fröhling, S; Springfeld, C [Durable remission under dual HER2 blockade with Trastuzumab and Pertuzumab in a patient with metastatic gallbladder cancer].
Z Gastroenterol. 2016; 54(5):426-430 Doi: 10.1055/s-0042-103498
Web of Science PubMed FullText FullText_MUG

 

Kadletz, L; Bigenzahn, J; Thurnher, D; Stanisz, I; Erovic, BM; Schneider, S; Schmid, R; Seemann, R; Birner, P; Heiduschka, G Evaluation of Polo-like kinase 1 as a potential therapeutic target in Merkel cell carcinoma.
Head Neck. 2016; 38 Suppl 1(8):E1918-E1925 Doi: 10.1002/hed.24349
Web of Science PubMed FullText FullText_MUG

 

Schneider, S; Thurnher, D; Kadletz, L; Seemann, R; Brunner, M; Kotowski, U; Schmid, R; Lill, C; Heiduschka, G Effects of neratinib and combination with irradiation and chemotherapy in head and neck cancer cells.
Oral Dis. 2016; 22(8):797-804 Doi: 10.1111/odi.12552
Web of Science PubMed FullText FullText_MUG

 

Willmes, C; Kumar, R; Becker, JC; Fried, I; Rachakonda, PS; Poppe, LM; Hesbacher, S; Schadendorf, D; Sucker, A; Schrama, D; Ugurel, S SERPINB1 expression is predictive for sensitivity and outcome of cisplatin-based chemotherapy in melanoma.
Oncotarget. 2016; 7(9): 10117-10132. Doi: 10.18632/oncotarget.6956 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Wilson, JM; Fokas, E; Dutton, SJ; Patel, N; Hawkins, MA; Eccles, C; Chu, KY; Durrant, L; Abraham, AG; Partridge, M; Woodward, M; O'Neill, E; Maughan, T; McKenna, WG; Mukherjee, S; Brunner, TB ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer.
Radiother Oncol. 2016; 119(2):306-11 Doi: 10.1016/j.radonc.2016.03.021 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Fischer, C; Leithner, K; Wohlkoenig, C; Quehenberger, F; Bertsch, A; Olschewski, A; Olschewski, H; Hrzenjak, A Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilization.
Mol Cancer. 2015; 14(8):4-4 Doi: 10.1186/1476-4598-14-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Haymerle, G; Thurnher, D; Kadletz, L; Stanisz, I; Brunner, M; Kotowski, U; Enzenhofer, E; Heiduschka, G Assessment of caroverine as a potential chemotherapeutical agent in HNSCC cell lines.
Eur Arch Otorhinolaryngol. 2015; 272(11):3451-3456 Doi: 10.1007/s00405-014-3364-0
Web of Science PubMed FullText FullText_MUG

 

Hilbe, W; Pall, G; Kocher, F; Pircher, A; Zabernigg, A; Schmid, T; Schumacher, M; Jamnig, H; Fiegl, M; Gächter, A; Freund, M; Kendler, D; Manzl, C; Zelger, B; Popper, H; Wöll, E Multicenter Phase II Study Evaluating Two Cycles of Docetaxel, Cisplatin and Cetuximab as Induction Regimen Prior to Surgery in Chemotherapy-Naive Patients with NSCLC Stage IB-IIIA (INN06-Study).
PLoS One. 2015; 10(5):e0125364-e0125364 Doi: 10.1371/journal.pone.0125364 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kadletz, L; Heiduschka, G; Domayer, J; Schmid, R; Enzenhofer, E; Thurnher, D Evaluation of spheroid head and neck squamous cell carcinoma cell models in comparison to monolayer cultures.
Oncol Lett. 2015; 10(3):1281-1286 Doi: 10.3892/ol.2015.3487 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kotowski, U; Heiduschka, G; Seemann, R; Eckl-Dorna, J; Schmid, R; Kranebitter, V; Stanisz, I; Brunner, M; Lill, C; Thurnher, D Effect of the coffee ingredient cafestol on head and neck squamous cell carcinoma cell lines.
Strahlenther Onkol. 2015; 191(6):511-517 Doi: 10.1007/s00066-014-0807-x
Web of Science PubMed FullText FullText_MUG

 

Mayr, C; Wagner, A; Neureiter, D; Pichler, M; Jakab, M; Illig, R; Berr, F; Kiesslich, T The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells.
BMC Complement Altern Med. 2015; 15(6):194-194 Doi: 10.1186/s12906-015-0721-5 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Selzer, E; Grah, A; Heiduschka, G; Kornek, G; Thurnher, D Primary radiotherapy or postoperative radiotherapy in patients with head and neck cancer: Comparative analysis of inflammation-based prognostic scoring systems.
Strahlenther Onkol. 2015; 191(6):486-494 Doi: 10.1007/s00066-014-0803-1
Web of Science PubMed FullText FullText_MUG

 

Stotz, M; Gerger, A; Haybaeck, J; Kiesslich, T; Bullock, MD; Pichler, M Molecular Targeted Therapies in Hepatocellular Carcinoma: Past, Present and Future.
Anticancer Res. 2015; 35(11):5737-5744
Web of Science PubMed

 

Volgger, B; Zeimet, AG; Reinthaller, A; Petru, E; Schauer, C; Klein, M; Sevelda-Schwarzgruber, U; Bogner, G; Wolfram, G; Marth, C Carboplatin and nonpegylated liposomal doxorubicin in primary advanced or recurrent endometrial cancer: a phase 2 trial conducted by AGO Austria.
Int J Gynecol Cancer. 2015; 25(2):257-262 Doi: 10.1097/IGC.0000000000000352 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Weitere 50 Treffer anzeigen

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum